Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R. Page 32588) - Meeting **New TIME: 8 a.m.EVENT: Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R.
Page 32588) holds a joint meeting of the Peripheral and Central Nervous System Drugs Advisory Committee and the...
Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R. Page 32588) - Meeting Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R.Page 32588) **New TIME: 8 a.m.
EVENT: Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R.
Page 32588) holds a joint...
U.S. review: Suicidal actions linked with epilepsy drugs WASHINGTON (Reuters) - Epilepsy drugs are associated with a higher risk of suicidal thoughts and behavior, U.S.drug reviewers said in an analysis that was released on Wednesday and mirrored earlier findings.
'The effect appears...
US FDA Grants Pediatric Exclusivity For UCB's Keppra® UCB announced recently that the US Food and Drug Administration (FDA) has granted pediatric exclusivity for Keppra (levetiracetam).The decision was based on pediatric data submitted to the FDA following a written request in 2001.
UCB and Otsuka to co-promote Keppra and Cimzia in Japan UCB and Otsuka will co-promote the anti-epileptic drug (AED), Keppra (levetiracetam) for the adjunctive treatment of partial onset seizures and the anti-TNF alpha drug, Cimzia (certolizumab pegol) for the treatment of Crohn's disease....
Otsuka, UCB to promote keppra and cimzia in Japan Belgium-based biopharmaceutical firm UCB and Japans Otsuka Pharmaceuticals have signed collaboration agreements related to UCB's two important products in Japan.UCB and Otsuka will co-promote the anti-epileptic drug, keppra and the...
New Compounds, Novel Applications Described Several new substances and new uses for available products were evaluated in research projects reported at the 47th annual NIMH-sponsored New Clinical Drug Evaluation Unit, held this past June in Boca Raton, Fla.The agonists included a...
Otsuka and UCB agreed to co-develop and co-promote Keppra(R) and Cimzia(R) in Japan at 7:00 am CEST - UCB and Otsuka Pharmaceuticals Co., Ltd.announced today that the companies have signed collaboration agreements related to UCB's two important products in Japan.
UCB and Otsuka will co-promote the anti-epileptic drug ...
Otsuka and UCB Agreed to Co-Develop and Co-Promote Keppra and Cimzia in Japan Otsuka and UCB have agreed to co-promote UCB's anti epileptic drug, Keppra and its anti-TNF alpha drug, Cimzia in Japan - the second largest pharmaceutical market in the world.Otsuka will also co-develop new indications.
Over time...
Otsuka, UCB to Co-promote Drugs in Japan UCBand Otsuka Pharmaceuticals Co.have signed collaboration agreements under which the two companies will co-promote the anti-epileptic drug, Keppra and Cimzia for the treatment of Crohn's Disease, in Japan.
They will also co...
Otsuka and UCB Agreed to Co-develop and Co-promote Keppra and Cimzia in Japan Otsuka and UCB have agreed to co-promote UCB's anti epileptic drug, Keppra and its anti-TNF alpha drug, Cimzia in Japan - the second largest pharmaceutical market in the world.Otsuka will also co-develop new indications.
Over time...
FDA grants pediatric exclusivity for UCB's Keppra UCBhas announced that the US Food and Drug Administration (FDA) has granted pediatric exclusivity for Keppra (levetiracetam).The decision was based on pediatric data submitted to the FDA following a written request in 2001.
The ...
FDA Says 11 Epilepsy Drugs May Get New Suicide Warnings Nidhi Sharma - AHN News Writer Washington D.C.(AHN) - The Food and Drug Administration is very close to finalizing new suicide warnings for 11 anti-seizure medications after research showed they increased patients' risk of suicidal...
FDA grants paediatric exclusivity for UCB's Keppra Belgium's UCB says that the US Food and Drug Administration has granted paediatric exclusivity to its blockbuster epilepsy treatment Keppra, extended the exclusivity on its patent by six months.The decision was based on paediatric...
UCB granted pediatric exclusivity for epilepsy drug Keppra by U.S. FDA BRUSSELS (Thomson Financial) - Belgian pharmaceutical company UCB (News) announced Friday that the U.S.Food and Drug Administration (FDA) has granted it pediatric exclusivity for the epilepsy treatment Keppra.
The decision was...
UCB granted pediatric exclusivity for epilepsy drug Keppra by U.S. FDA BRUSSELS (Thomson Financial) - Belgian pharmaceutical company UCB announced Friday that the U.S.Food and Drug Administration (FDA) has granted it pediatric exclusivity for the epilepsy treatment Keppra.
The decision was based on...
UCB granted pediatric exclusivity for epilepsy drug Keppra by U.S. FDA BRUSSELS (Thomson Financial) - Belgian pharmaceutical company UCB announced Friday that the U.S.Food and Drug Administration (FDA) has granted it pediatric exclusivity for the epilepsy treatment Keppra.
The decision was based on...
US FDA Grants Pediatric Exclusivity for UCB's Keppra Period of exclusivity until January 2009 in the US Pediatric indication filed with FDA Brussels, BELGIUM - June 6, 2008 at 7:00 am CEST - UCB announced today that the US Food and Drug Administration (FDA) has granted pediatric exclusivity...
UCB granted pediatric exclusivity for epilepsy drug Keppra by U.S. FDA BRUSSELS (Thomson Financial) - Belgian pharmaceutical company UCB announced Friday that the U.S.Food and Drug Administration (FDA) has granted it pediatric exclusivity for the epilepsy treatment Keppra.
The decision was based on...
Health Highlights: June 4, 2008 FDA Data Notes Possible Link Between Suicidal Behavior and Epilepsy Drugs: Report A group of 11 popular epilepsy drugs may be linked to suicidal behavior among users, according to an unpublished analysis from the U.S.Food and Drug...
US FDA Grants Pediatric Exclusivity for UCB's Keppra - Period of exclusivity until January 2009 in the US SMYRNA, Ga., June 06, 2008 /PRNewswire/ -- UCB announced today that the US Food and Drug Administration (FDA) has granted pediatric exclusivity for Keppra(R) (levetiracetam).The...
Health Highlights: June 4, 2008 Here are some of the latest health and medical news developments, compiled by editors of HealthDay: FDA Data Notes Possible Link Between Suicidal Behavior and Epilepsy Drugs: Report A group of 11 popular epilepsy drugs may be linked to...
Health Highlights: June 4, 2008 Here are some of the latest health and medical news developments, compiled by editors of HealthDay: FDA Data Notes Possible Link Between Suicidal Behavior and Epilepsy Drugs: Report A group of 11 popular epilepsy drugs may be linked to...
Pharmacotherapy, Epilepsy, and Comorbidities: Causes for Concern Pharmacotherapy, Epilepsy, and Comorbidities: Causes for Concern Claire Sowerbutt CLAIRE SOWERBUTT is a freelance medical news writer in Vancouver, British Columbia.Many persons with epilepsy have comorbid conditions that are treated with...
Health Highlights: June 4, 2008 FDA Data Notes Possible Link Between Suicidal Behavior and Epilepsy Drugs: Report Cigarette Decline Outpaces Marijuana Drop Among Teens Merck Won't Have to Monitor Uninjured Vioxx Users: Court Asian-Pacific Islanders at Greater Risk of...
